Literature DB >> 6277865

Cyclic AMP may not be involved in catabolite repression in Saccharomyes cerevisiae: evidence from mutants capable of utilizing it as an adenine source.

K Matsumoto, I Uno, A Toh-E, T Ishikawa, Y Oshima.   

Abstract

Mutants able to utilize 5'-AMP or cyclic AMP as the adenine source were isolated from an ade6 ade10 double mutant by ethyl methane sulfonate mutagenesis. A single amp1 mutation, primarily selected on 5'-AMP medium, confers the phenotype for utilization of exogenous 5'-AMP as the adenine source. From the ade6 ade10 amp1 triple mutant, a mutant able to utilize cyclic AMP was isolated, and the mutant phenotype was proven to be due to the simultaneous occurrence of triple mutations designated as cam1, cam2, and cam3. The cam3 mutation, but not cam1 or cam2, also confers the phenotype for utilizing 5'-AMP, the same phenotype as the amp1 mutation. All of these mutations are recessive to the respective wild-type counterparts. Cells having the ade6 ade10 amp1 cam1 cam2 cam3 genotype showed significant ability to take up exogenous cyclic AMP, whereas no differences were observed in cyclic AMP phosphodiesterase activity in comparison with that of the original strains used in the mutant isolation. Since glucose severely repressed galactokinase synthesis in the constitutive GAL81 mutant having the ade6 ade10 amp1 cam1 cam2 cam3 genotype, irrespective of the presence or absence of cyclic AMP in the medium, it was suggested that cyclic AMP is not involved in the mechanism of catabolite repression in Saccharomyces cerevisiae. It does, however, have a stimulative effect on the galactokinase synthesis in the GAL81 mutant in the absence of glucose.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6277865      PMCID: PMC220110          DOI: 10.1128/jb.150.1.277-285.1982

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  22 in total

1.  Cyclic 3', 5'-amp in Saccharomyces carlsbergensis under various conditions of catabolite repression.

Authors:  R Van Wijk; T M. Konijn
Journal:  FEBS Lett       Date:  1971-03-05       Impact factor: 4.124

2.  Genetic control of galactokinase synthesis in Saccharomyces cerevisiae: evidence for constitutive expression of the positive regulatory gene gal4.

Authors:  K Matsumoto; A Toh-e; Y Oshima
Journal:  J Bacteriol       Date:  1978-05       Impact factor: 3.490

3.  Cyclic 3',5'-AMP phosphodiesterase of Neurospora crassa.

Authors:  W A Scott; B Solomon
Journal:  Biochem Biophys Res Commun       Date:  1973-08-06       Impact factor: 3.575

4.  Nucleotide reversal of mitochondrial repression in Saccharomyces cerevisiae.

Authors:  M Fang; R A Butow
Journal:  Biochem Biophys Res Commun       Date:  1970-12-24       Impact factor: 3.575

5.  Lac DNA, RNA polymerase and cyclic AMP receptor protein, cyclic AMP, lac repressor and inducer are the essential elements for controlled lac transcription.

Authors:  B De Crombrugghe; B Chen; W Anderson; P Nissley; M Gottesman; I Pastan; R Perlman
Journal:  Nat New Biol       Date:  1971-06-02

6.  Cyclic AMP receptor protein of E. coli: its role in the synthesis of inducible enzymes.

Authors:  M Emmer; B deCrombrugghe; I Pastan; R Perlman
Journal:  Proc Natl Acad Sci U S A       Date:  1970-06       Impact factor: 11.205

Review 7.  Possible role for cyclic nucleotides and phosphorylated membrane proteins in postsynaptic actions of neurotransmitters.

Authors:  P Greengard
Journal:  Nature       Date:  1976-03-11       Impact factor: 49.962

8.  Saccharomyces mutants with invertase formation resistant to repression by hexoses.

Authors:  B S Montenecourt; S C Kuo; J O Lampen
Journal:  J Bacteriol       Date:  1973-04       Impact factor: 3.490

9.  Interaction of super-repressible and dominant constitutive mutations for the synthesis of galactose pathway enzymes in Saccharomyces cerevisiae.

Authors:  Y Nogi; K Matsumoto; A Toh-e; Y Oshima
Journal:  Mol Gen Genet       Date:  1977-04-29

10.  Isolation and characterization of dominant mutations resistant to carbon catabolite repression of galactokinase synthesis in Saccharomyces cerevisiae.

Authors:  K Matsumoto; A Toh-e; Y Oshima
Journal:  Mol Cell Biol       Date:  1981-02       Impact factor: 4.272

View more
  29 in total

1.  Cloning and characterization of the low-affinity cyclic AMP phosphodiesterase gene of Saccharomyces cerevisiae.

Authors:  J Nikawa; P Sass; M Wigler
Journal:  Mol Cell Biol       Date:  1987-10       Impact factor: 4.272

Review 2.  Regulation of sugar utilization in Saccharomyces species.

Authors:  M Carlson
Journal:  J Bacteriol       Date:  1987-11       Impact factor: 3.490

Review 3.  A model fungal gene regulatory mechanism: the GAL genes of Saccharomyces cerevisiae.

Authors:  M Johnston
Journal:  Microbiol Rev       Date:  1987-12

4.  Consequences of growth media, gene copy number, and regulatory mutations on the expression of the PRB1 gene of Saccharomyces cerevisiae.

Authors:  C M Moehle; E W Jones
Journal:  Genetics       Date:  1990-01       Impact factor: 4.562

5.  Identification of the structural gene and nonsense alleles for adenylate cyclase in Saccharomyces cerevisiae.

Authors:  K Matsumoto; I Uno; T Ishikawa
Journal:  J Bacteriol       Date:  1984-01       Impact factor: 3.490

6.  Is there a general paradigm of cyclic AMP action in eukaryotes?

Authors:  M L Pall
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

7.  Phenotypic expression of Kluyveromyces lactis killer toxin against Saccharomyces spp.

Authors:  C J Panchal; C Meacher; J Van Oostrom; G G Stewart
Journal:  Appl Environ Microbiol       Date:  1985-08       Impact factor: 4.792

8.  Fluphenazine-resistant Saccharomyces cerevisiae mutants defective in the cell division cycle.

Authors:  K Matsumoto; I Uno; T Ishikawa
Journal:  J Bacteriol       Date:  1986-12       Impact factor: 3.490

9.  A dominant interfering mutation (CYR3) of the Saccharomyces cerevisiae RAS2 gene.

Authors:  T Morishita; I Uno
Journal:  J Bacteriol       Date:  1991-07       Impact factor: 3.490

10.  Use of a yeast expression system for the isolation and analysis of drug-resistant mutants of a mammalian phosphodiesterase.

Authors:  R Pillai; K Kytle; A Reyes; J Colicelli
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.